Integrating machine learning algorithms to systematically assess reactive oxygen species levels to aid prognosis and novel treatments for triple -negative breast cancer patients
IntroductionBreast cancer has become one of the top health concerns for women, and triple-negative breast cancer (TNBC) leads to treatment resistance and poor prognosis due to its high degree of heterogeneity and malignancy. Reactive oxygen species (ROS) have been found to play a dual role in tumors...
Main Authors: | Juan Li, Yu Liang, Xiaochen Zhao, Chihua Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-06-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1196054/full |
Similar Items
-
Emergence of Nanotechnology as a Powerful Cavalry against Triple-Negative Breast Cancer (TNBC)
by: Aiswarya Chaudhuri, et al.
Published: (2022-04-01) -
Efficacy and Safety of Capecitabine for Triple-Negative Breast Cancer: A Meta-Analysis
by: Xueqiong Xun, et al.
Published: (2022-07-01) -
Does the Dose of Standard Adjuvant Chemotherapy Affect the Triple-negative Breast Cancer Benefit from Extended Capecitabine Metronomic Therapy? An Exploratory Analysis of the SYSUCC-001 Trial
by: Chen Y, et al.
Published: (2024-04-01) -
Characterizing the Inflammatory Profile of Neutrophil-Rich Triple-Negative Breast Cancer
by: Fatma Al Qutami, et al.
Published: (2024-02-01) -
MicroRNAs Involved in Carcinogenesis, Prognosis, Therapeutic Resistance and Applications in Human Triple-Negative Breast Cancer
by: Lei Ding, et al.
Published: (2019-11-01)